Fosinopril Sodium Tablet
Product Images NDC 76282-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 76282-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemstr)

FDA Label Image

10 mg (Fosinopril10mg)

10 mg (Fosinopril10mg)
FOSINOPRIL SODIUM is a medication that comes in the form of tablets and each container contains 90 tablets which meet the USP standards. The container has a child-resistant closure. The medication should be kept away from children. The manufacturer is Exeltis Pharmaceuticals and the tablets are sold only by prescription. The location of the manufacturer is Boca Raton, FL 3432. No other useful information can be obtained from this text.*
FDA Label Image

20 mg (Fosinopril20mg)

20 mg (Fosinopril20mg)
This is a medication label for Fosinopril Sodium tablets, USP. The tablets are manufactured by Invaen Pharmaceuticals, Inc. and are available in a 90 tablet packaging. The label contains instructions to keep medication away from children and also includes a unique product identifier code, NDC76282201-90.*
FDA Label Image

40 mg (Fosinopril40mg)

40 mg (Fosinopril40mg)
This is a prescription medication container label for Fosinopril Sodium Tablets, USP containing 90 tablets, each of which contains 40 mg of Fosinopril USP. The medication should be stored at a temperature between 20°C - 25°C, in a controlled room temperature environment. The recommended dosage should be followed as per the package insert for the medication. It should be kept out of reach of children and stored in a tightly closed container. The label indicates that the medication is manufactured by InvaGen Pharmaceutical, Inc, and is the subsidiary of Cipla Ltd. It is manufactured for Exelan Pharmaceuticals, Inc, located in Boca Raton, FL 33432, and has a unique identification number of 218905.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.